Clinical trials sponsored by Hubei Cancer Hospital
8
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 2 2Not applicable 6
Conditions studied
Recruiting trials led by Hubei Cancer Hospital
- A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
- DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
- Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
- Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
- Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
- Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
- SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
- Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients
Common questions
How many trials is Hubei Cancer Hospital recruiting for?
Hubei Cancer Hospital is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.